Search
for
Sort by
Research 121–150 of 508
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- Recent advances in the genetics of alopecia areata
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- 097 LFA-1 blockade prevents the onset of alopecia areata in C3H/HeJ mice
- Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- Pro-inflammatory Vδ1+T-cells infiltrates are present in and around the hair bulbs of non-lesional and lesional alopecia areata hair follicles
- Hair follicle immune privilege and its collapse in alopecia areata
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- Maintenance of Hair Follicle Immune Privilege Is Linked to Prevention of NK Cell Attack
- Overview of Alopecia Areata
- Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- JAK Inhibitors for Treatment of Alopecia Areata
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Alopecia areata: medical treatments
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- What is behind the ‘swarm of bees’ in alopecia areata
- Janus kinase inhibitors for alopecia areata: A narrative review
- CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata
- Blocking Potassium Channels (Kv1.3): A New Treatment Option for Alopecia Areata?
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Dietary Habits in Japanese Patients with Alopecia Areata
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Clinical Translation of Microbiome Research in Alopecia Areata: A New Perspective?
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo
- Laser Capture Microdissection Reveals Transcriptional Abnormalities in Alopecia Areata before, during, and after Active Hair Loss
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway